Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies-Reference-Cited by-同舟云学术

Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies

Published:2013-10-25 Issue:1 Volume:73 Page:79-86
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Xu Wei-qun,Zhang Ling-yan,Chen Xue-ying,Pan Bin-hua,Mao Jun-qing,Song Hua,Li Jing-yuang,Tang Yong-min

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-013-2319-2.pdf

Reference19 articles.

1. Pui CH (2010) Recent research advances in childhood acute lymphoblastic leukemia. J Formos Med Assoc 109:777–787

2. Rask C, Albertioni F, Bentzen SM, Schroeder H, Peterson C (1998) Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia–a logistic regression analysis. Acta Oncol 37:277–284

3. Relling MV, Fairclough D, Ayers D, Crom WR, Rodman JH, Pui CH, Evans WE (1994) Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol 12:1667–1672

4. Xu W, Tang Y, Song H, Shi S, Yang S (2007) Retrospective study on elimination delay of methotrexate in high-dose therapy of childhood acute lymphoblastic leukemia in China. J Pediatr Hematol Oncol 29:688–693

5. Takami M, Kuniyoshi Y, Oomukai T, Ishida T, Yamano Y (1995) Severe complications after high-dose methotrexate treatment. Acta Oncol 34:611–612

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies;Cancer Chemotherapy and Pharmacology;2024-06-21

2. Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy;Cancer Chemotherapy and Pharmacology;2024-03-13

3. Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies;2024-02-28

4. Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients;Frontiers in Oncology;2023-10-26

5. Early clinical indicators of acute kidney injury caused by administering high-dose methotrexate therapy to juvenile pigs;Frontiers in Nephrology;2023-09-12